Contact
Please use this form to send email to PR contact of this press release:
Immutep Signs Exclusive License Agreement with Cardiff University for Next Generation Anti-LAG-3 Molecules for Cancer
TO:
Please use this form to send email to PR contact of this press release:
Immutep Signs Exclusive License Agreement with Cardiff University for Next Generation Anti-LAG-3 Molecules for Cancer
TO: